AIMS: Denervation of the bladder is a detrimental consequence of bladder outlet obstruction (BOO). We have previously shown that, during BOO, inflammation triggered by the NLRP3 inflammasome in the urothelia mediates physiological bladder dysfunction and downstream fibrosis in rats. The aim of this study was to assess the effect of NLRP3-mediated inflammation on bladder denervation during BOO. METHODS: There were five groups of rats: (i) Control (no surgery); (ii) Sham-operated; (iii) BOO rats given vehicle; (iv) BOO rats given the NLRP3 inhibitor glyburide; and (v) BOO rats given the IL-1 receptor antagonist anakinra. BOO was constructed by ligating the urethra over a 1 mm catheter and removing the catheter. Medications were given prior to surgery and once daily for 12 days. Bladder sections were stained for PGP9.5, a pan-neuronal marker. Whole transverse sections were used to identify and count nerves while assessing cross-sectional area. For in vitro studies, pelvic ganglion neurons were isolated and treated with IL-1β. After a 48 h incubation apoptosis, neurite length and branching were assessed. RESULTS: In obstructed bladders, the number of nerves decreased while total area increased, indicating a loss of cell number and/or branching. The decrease in nerve density was blocked by glyburide or anakinra, clearly implicating the NLRP3 pathway in denervation. In vitro analysis demonstrated that IL-1β, a product of the inflammasome, induced apoptosis in pelvic ganglion neurons, suggesting one mechanism of BOO-induced denervation is NLRP3/IL-1β triggered apoptosis. CONCLUSIONS: The NLRP3/IL-1β-mediated inflammation pathway plays a significant role in denervation during BOO.
AIMS: Denervation of the bladder is a detrimental consequence of bladder outlet obstruction (BOO). We have previously shown that, during BOO, inflammation triggered by the NLRP3 inflammasome in the urothelia mediates physiological bladder dysfunction and downstream fibrosis in rats. The aim of this study was to assess the effect of NLRP3-mediated inflammation on bladder denervation during BOO. METHODS: There were five groups of rats: (i) Control (no surgery); (ii) Sham-operated; (iii) BOO rats given vehicle; (iv) BOO rats given the NLRP3 inhibitor glyburide; and (v) BOO rats given the IL-1 receptor antagonist anakinra. BOO was constructed by ligating the urethra over a 1 mm catheter and removing the catheter. Medications were given prior to surgery and once daily for 12 days. Bladder sections were stained for PGP9.5, a pan-neuronal marker. Whole transverse sections were used to identify and count nerves while assessing cross-sectional area. For in vitro studies, pelvic ganglion neurons were isolated and treated with IL-1β. After a 48 h incubation apoptosis, neurite length and branching were assessed. RESULTS: In obstructed bladders, the number of nerves decreased while total area increased, indicating a loss of cell number and/or branching. The decrease in nerve density was blocked by glyburide or anakinra, clearly implicating the NLRP3 pathway in denervation. In vitro analysis demonstrated that IL-1β, a product of the inflammasome, induced apoptosis in pelvic ganglion neurons, suggesting one mechanism of BOO-induced denervation is NLRP3/IL-1β triggered apoptosis. CONCLUSIONS: The NLRP3/IL-1β-mediated inflammation pathway plays a significant role in denervation during BOO.
Authors: Megan G Massa; Christina David; Stefanie Jörg; Johannes Berg; Barbara Gisevius; Sarah Hirschberg; Ralf A Linker; Ralf Gold; Aiden Haghikia Journal: Am J Pathol Date: 2017-07 Impact factor: 4.307
Authors: Rik de Jongh; Miriam Dambros; Guido R M M Haenen; Gertjan J M den Hartog; Aalt Bast; Philip E V van Kerrebroeck; Gommert A van Koeveringe Journal: Neurourol Urodyn Date: 2009 Impact factor: 2.696
Authors: Peter Nyirady; Nikesh Thiruchelvam; Christopher H Fry; Margaret L Godley; Paul J D Winyard; Donald M Peebles; Adrian S Woolf; Peter M Cuckow Journal: J Urol Date: 2002-10 Impact factor: 7.450
Authors: Francis M Hughes; Hayden M Hill; Case M Wood; Andrew T Edmondson; Aliya Dumas; Wen-Chi Foo; James M Oelsen; Goran Rac; J Todd Purves Journal: J Urol Date: 2015-12-18 Impact factor: 7.450
Authors: D Yang-Wei Fann; S Y Lee; S Manzanero; S C Tang; M Gelderblom; P Chunduri; C Bernreuther; M Glatzel; Y L Cheng; J Thundyil; A Widiapradja; K Z Lok; S L Foo; Y C Wang; Y I Li; G R Drummond; M Basta; T Magnus; D G Jo; M P Mattson; C G Sobey; T V Arumugam Journal: Cell Death Dis Date: 2013-09-05 Impact factor: 8.469
Authors: Francis M Hughes; Nathan A Hirshman; Brian M Inouye; Huixia Jin; Eloise W Stanton; Chloe E Yun; Leah G Davis; Jonathan C Routh; J Todd Purves Journal: Diabetes Date: 2018-11-13 Impact factor: 9.461
Authors: Francis M Hughes; Shelby N Harper; Brent D Nosé; Armand Allkanjari; Michael T Zheng; Huixia Jin; J Todd Purves Journal: Am J Physiol Renal Physiol Date: 2021-08-16
Authors: Francis M Hughes; Stephanie J Sexton; Patrick D Ledig; Chloe E Yun; Huixia Jin; J Todd Purves Journal: Am J Physiol Renal Physiol Date: 2018-10-24
Authors: Francis M Hughes; Nathan A Hirshman; Hamza A Malick; Simon W White; Huixia Jin; Shelby N Harper; J Todd Purves Journal: Neurourol Urodyn Date: 2020-06-29 Impact factor: 2.696
Authors: Brian M Inouye; Francis M Hughes; Huixia Jin; Robin Lütolf; Kunal C Potnis; Jonathan C Routh; Douglas C Rouse; Wen-Chi Foo; J Todd Purves Journal: Res Rep Urol Date: 2018-11-16
Authors: Grzegorz Niemczyk; Lukasz Fus; Katarzyna Czarzasta; Anika Jesion; Piotr Radziszewski; Barbara Gornicka; Agnieszka Cudnoch-Jedrzejewska Journal: Biomed Res Int Date: 2020-12-12 Impact factor: 3.411